Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Generation of Standard Laboratory Values for Pneumococci Antibodies

This study has been completed.
Information provided by:
Johann Wolfgang Goethe University Hospital Identifier:
First received: December 4, 2007
Last updated: January 14, 2011
Last verified: October 2007
The determination of reference values is a necessary basis for research and clinical routine testing for pneumococci antibodies

Reference Values

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Generation of Standard Laboratory Values for Pneumococci Antibodies

Further study details as provided by Johann Wolfgang Goethe University Hospital:

Primary Outcome Measures:
  • sufficient samples to calculate reference values [ Time Frame: 10(2006-10/2007) ]

Secondary Outcome Measures:
  • sufficient samples to correlate with screening assay [ Time Frame: 10/2006-10/2007 ]

Biospecimen Retention:   Samples Without DNA
human serum

Enrollment: 500
Study Start Date: October 2006
Study Completion Date: December 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Detailed Description:
This study is meant to determine specific pneumococcal antibodies stratified for age. The investigators also correlate our assay with the results from a commercially available pneumococcal screening ELISA (iGG1 and IgG2) in order to facilitate a screening for immunodeficiency, and to monitor the success of a performed immunization

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
any clinically and immunologically healthy subject of any age undergoing selective surgery

Inclusion Criteria:

  • Subjects undergoing elective surgery

Exclusion Criteria:

  • Chronic illness condition,
  • Immunodeficiency
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00567632

Goethe University, Department of Pulmonology
Frankfurt, Hessen, Germany, 60590
Sponsors and Collaborators
Johann Wolfgang Goethe University Hospital
Study Chair: Markus A Rose, M.D., Ph.D., M.P.H Goethe University, childrens Hospital
  More Information

Responsible Party: Markus A. Rose, ass. Professor of Paediatrics, Goethe University, Childrens' Hospital Identifier: NCT00567632     History of Changes
Other Study ID Numbers: 1-Rose
Study First Received: December 4, 2007
Last Updated: January 14, 2011

Keywords provided by Johann Wolfgang Goethe University Hospital:
Standard laboratory values

Additional relevant MeSH terms:
Immunologic Factors
Physiological Effects of Drugs processed this record on May 25, 2017